In contrast, depletion of CD8+ T cells in transgenic mice abrogated the OV-CXCR4 treatment-mediated control of tumor growth, restoring primary tumor growth to the level of untreated mice (p = 0.007). This evidence concerns the gene CD8A and neoplasm.